Intellipharmaceutics International Inc. (IPCI)

[Samsa]

Tekterra....That is what actually frustrated me about the new coverage. Its like they do not even know the company. Take Rexista out of the equation. the stock should be trading much higher just off the ANDA's. already by 2018 we should be seeing revenue around 21 to 24 mill. just on Focalin and full year of Seroquel. add another 10 mill. if they get full year of another MNK partnered drug. which means they need just 1 approved before year end, which is highly probable. add maybe 6 mill if they partner Glucho.

so added together I come up with 37 to 38 mill in revenue on 13 mill. in expenses or roughly 25 mill profit! yet they only see potential of $7 in 2 years?

This company is more than just Rexista. the sad part is thats all anyone ever focuses on. the big deal which should bring in the big pop to get us to $7 in one to two days. the company should already be trading higher. and then we should have been looking forward to a nice $7 pop on top of that when the deal does hit.

but according to these guys. we will be earning close to 75 cents a share by the end of 2018 and still trading at $3 LOL